Zweig Advisers’s Gilead Sciences GILD Stock Holding History

Zweig Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-92,000	Closed	-$7.31M	–	29
2016 Q2	$7.31M	Sell	92,000 -12,000	-12%	-$1.06M	1.25%	38
2016 Q1	$9.55M	Hold	104,000	–	–	1.6%	43
2015 Q4	$10.5M	Hold	104,000	–	–	1.75%	28
2015 Q3	$10.2M	Sell	104,000 -11,000	-10%	-$1.22M	1.77%	25
2015 Q2	$13.5M	Sell	115,000 -14,000	-11%	-$1.53M	2.04%	8
2015 Q1	$12.7M	Buy	+129,000	New	+$13.1M	1.82%	25
2014 Q2	–	Sell	-141,000	Closed	-$9.99M	–	73
2014 Q1	$9.99M	Buy	141,000 +10,000	+8%	+$784K	1.42%	44
2013 Q4	$9.85M	Sell	131,000 -15,000	-10%	-$1.04M	1.35%	46
2013 Q3	$9.18M	Sell	146,000 -43,000	-23%	-$2.57M	1.36%	48
2013 Q2	$9.68M	Buy	+189,000	New	+$9.85M	1.49%	27

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zweig Advisers's GILD Position: Q3 2016 in Review

Zweig Advisers sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 92,000 shares — an estimated $7.31M sold.

Zweig Advisers first reported a position in GILD in Q2 2013 and held it in 10 quarters. The position peaked at $13.5M in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Zweig Advisers reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Zweig Advisers sold 92,000 Gilead Sciences shares in Q3 2016, an estimated $7.31M.
Zweig Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 10 quarters.
Zweig Advisers's Gilead Sciences position peaked at $13.5M in Q2 2015.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Zweig Advisers's 13F filing for Q3 2016.